Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSO4.L Regulatory News (SO4)

  • There is currently no data for SO4

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placement and Voluntary Suspension on ASX

23 Mar 2016 10:30

RNS Number : 0278T
Salt Lake Potash Limited
23 March 2016
 

23 March 2016

 

AIM/ASX Code: SO4

 

 

SALT LAKE POTASH LIMITED

Placement and Voluntary Suspension on ASX

 

Salt Lake Potash Limited (the Company or SO4) is pleased to announce that it has successfully completed the domestic tranche of a placement of 16,250,000 ordinary shares of no par value of the Company at an issue price of A$0.32 per share to institutional and sophisticated investors in Australia, to raise gross proceeds of A$5,200,000 (Placement).

Further, at the request the Company, trading on the Australian Securities Exchange for the Company's ordinary shares of no par value has been temporarily suspended from 23 March 2016 pending a further announcement regarding an additional capital raising.

The suspension was granted by the ASX at the Company's request in accordance with the ASX Listing Rules, in order to allow a proposed capital raise to be finalised. The Company anticipates the suspension on the ASX will remain in place until the earlier of such time it makes an announcement to the market in relation to the outcome of the proposed additional capital raise, or the commencement of trading on 24 March 2016. Trading in the Company's ordinary securities will continue on AIM during this period.

The Placement

Baillieu Holst Limited (Baillieu) and Argonaut Securities Pty Ltd (Argonaut) acted as Joint Lead Manager to the Placement, which was oversubscribed. The issue price of A$0.32 represents a 12.0% discount to the 20-day VWAP.

The Company expects to complete the placement on or about 31 March 2016 and expects to issue the Placement shares under Listing Rules 7.1 and 7.1A.

 

The Company has also received strong interest in equity funding from overseas based strategic and sophisticated agricultural investors and has requested a one day voluntary suspension of the Company's securities to finalise discussions with the interested parties.

 

Information required under ASX Listing Rule 3.10.5A:

(a) Dilution to existing shareholders as a result of the issue under Listing Rule 7.1A is 0.5%, dilution to existing shareholders as a result of the issue under Listing Rule 7.1 is 12.8% and the total dilution to existing shareholders is 13.3%. Details regarding the participation of existing and new shareholders is not able to be determined yet and will be provided at completion;

(b) The Company will issue 644,611 shares under Listing Rule 7.1A because the Placement was considered to be a more efficient mechanism for raising funds. The Placement did not expose the Company to additional costs, a protracted process and market volatility that may have been experienced with a pro-rata issue or other type of issue in which existing ordinary shareholders would have been eligible to participate;

(c) No underwriting arrangements are in place for the Placement under rule 7.1A; and

(d) A fee of up to 6% may be paid to Ballieu and Argonaut in connection with the Placement under rule 7.1A.

 

Settlement and dealings

 

Application will be made to the Australian Securities Exchange ("ASX") and the AIM market of the London Stock Exchange ("AIM") for 16,250,000 new ordinary shares, which rank pari passu with the Company's existing issued ordinary shares, to be admitted to trading on both the ASX and AIM. Dealings on AIM are expected to commence at 8:00 a.m. on or around 5 April 2016 ("Admission").

 

Following the Admission of the new ordinary shares, the Company's issued share capital will comprise 122,302,596 ordinary shares. The Company does not hold any shares in treasury. This figure of 122,302,596 ordinary shares may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Forward Looking Statements

This announcement may include forward-looking statements. These forward-looking statements are based on Salt Lake Potash Limited's expectations and beliefs concerning future events. Forward looking statements are necessarily subject to risks, uncertainties and other factors, many of which are outside the control of Salt Lake Potash Limited, which could cause actual results to differ materially from such statements. Salt Lake Potash Limited makes no undertaking to subsequently update or revise the forward-looking statements made in this announcement, to reflect the circumstances or events after the date of that announcement.

 

For further information please visit www.saltlakepotash.com.au or contact:

Sam Cordin

Salt Lake Potash Limited

Tel: +61 8 9322 6322

Colin Aaronson/Richard Tonthat/Daniel Bush

Grant Thornton UK LLP

Tel: +44 (0)207 383 5100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUOURRNOAOUAR
Date   Source Headline
25th Mar 20217:00 amRNSHolding(s) in Company
22nd Mar 20217:00 amRNSLake Way Process Plant commissioning commences
16th Mar 20217:45 amRNSInterim Results
10th Mar 20217:00 amRNSCompany Presentation - Project Update
4th Mar 20217:00 amRNSSenior debt syndication to Sequoia and CBA
12th Feb 20218:42 amRNSDirector/PDMR Shareholding
11th Feb 20217:06 amRNSCompletion of Placement and Issue of Shares
3rd Feb 20217:00 amRNSIssue of Share Purchase Plan Shares
29th Jan 20217:00 amRNSDecember 2020 Quarterly Report
28th Jan 20217:00 amRNSSO4 Successfully Completes Share Purchase Plan
22nd Jan 20218:58 amRNSResult Of General Meeting
18th Jan 20217:00 amRNSLake Way Project Update. Interim CFO appointed
22nd Dec 20207:36 amRNSFunds from First Drawdown Received
21st Dec 20207:00 amRNSNotice of General Meeting
18th Dec 20209:15 amRNSPlacement, Share Purchase Plan, Securities Issue
11th Dec 20207:00 amRNSFundraising & Lifting of ASX Voluntary Suspension
10th Dec 20207:00 amRNSFunding Update & Short Extension to ASX Suspension
3rd Dec 20207:00 amRNSASX Voluntary Suspension and Funding Update
27th Nov 20203:39 pmRNSFunding Update
27th Nov 20207:00 amRNSASX Trading Halt
20th Nov 20207:00 amRNSResult of AGM
21st Oct 20207:15 amRNSNotice of AGM
19th Oct 20207:00 amRNSOperational and Potash Experience Added to Board
16th Oct 20207:00 amRNSSeptember 2020 Quarterly Report & Issue of Shares
14th Oct 20207:48 amRNSNew Corporate Presentation
12th Oct 20202:05 pmRNSSecond Price Monitoring Extn
12th Oct 20202:00 pmRNSPrice Monitoring Extension
29th Sep 202011:44 amRNSDirector and Other Shareholdings
28th Sep 20207:00 amRNSFinal Results
25th Sep 202011:04 amRNSDate of AGM and Delay to Admission of Shares
23rd Sep 202012:29 pmRNSAGM Statement. Issue of Ordinary Shares
14th Sep 20208:08 amRNSLake Way Project Reaches 60% Completion
3rd Sep 202010:21 amRNSHolding(s) in Company
1st Sep 20207:38 amRNSIssue of Shares - Director/PDMR Shareholding
28th Aug 20207:00 amRNSCompletion Of Retail Entitlement Offer
27th Aug 20207:00 amRNSHolding(s) in Company
24th Aug 20208:08 amRNSNotice of GM
20th Aug 202010:26 amRNSHolding(s) in Company
17th Aug 20207:00 amRNSIssue of Shares and Directors' Subscription
14th Aug 20207:00 amRNSDespatch of Retail Offer Booklet. Loan Conversion
11th Aug 20207:00 amRNSSuccessful Completion of Institutional Offer
6th Aug 20207:00 amRNSEntitlement Offer Amended Timetable for DI Holders
5th Aug 20207:00 amRNSDebt Facility, Equity Raising, Entitlement Offer
31st Jul 20207:00 amRNSJune 2020 Quarterly Report
13th Jul 20207:00 amRNSGreen Label Certification
9th Jul 20207:00 amRNSProcurement Update
3rd Jul 20209:30 amRNSAppendix 3Y Change of Director's Interest Notices
2nd Jul 20207:39 amRNSConvertible Note Placement
23rd Jun 20203:33 pmRNSHolding(s) in Company
17th Jun 20209:03 amRNSResult of Meeting. Completion of Placement.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.